Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mehrul Hasnain

Showing results (11-20 of 49) with videos related to

Pageof 5
Sort By:
Current Pharmaceutical Design|March 20, 2014
Possible role of vascular risk factors in Alzheimer's disease and vascular dementiaMehrul Hasnain, W Victor R Vieweg
Acta Psychiatrica Scandinavica|May 14, 2011
Do we truly appreciate how difficult it is for patients with schizophrenia to adapt a healthy lifestyle?Mehrul Hasnain, W Victor R Vieweg
CNS Drugs|August 30, 2014
QTc interval prolongation and torsade de pointes associated with second-generation antipsychotics and antidepressants: a comprehensive reviewMehrul Hasnain, W Victor R Vieweg
Journal of Psychopharmacology (Oxford, England)|March 23, 2011
Mortality in schizophreniaMehrul Hasnain, W Victor R Vieweg, Briana Mezuk
Postgraduate Medicine|August 24, 2012
Weight gain and glucose dysregulation with second-generation antipsychotics and antidepressants: a review for primary care physiciansMehrul Hasnain, W Victor R Vieweg, Bruce Hollett
CNS Drugs|February 17, 2010
Metformin for atypical antipsychotic-induced weight gain and glucose metabolism dysregulation: review of the literature and clinical suggestionsMehrul Hasnain, W Victor R Vieweg, Sonja K Fredrickson
The American Journal of Medicine|May 21, 2013
The replyW Victor R Vieweg, Mehrul Hasnain, Robert H Howland
The American Journal of Medicine|February 21, 2012
Coordinated medical and psychiatric care in schizophreniaW Victor R Vieweg, Mehrul Hasnain, Ananda K Pandurangi
Journal of Psychiatry & Neuroscience : JPN|June 25, 2013
Escitalopram and QTc prolongationMehrul Hasnain, Robert H Howland, W Victor R Vieweg
Journal of Psychopharmacology (Oxford, England)|December 21, 2010
Metformin for obesity and glucose dysregulation in patients with schizophrenia receiving antipsychotic drugsMehrul Hasnain, Sonja K Fredrickson, W Victor R Vieweg
Pageof 5

Showing results (11-20 of 49) with videos related to

Sort By:
Pageof 5
Current Pharmaceutical Design|March 20, 2014
Possible role of vascular risk factors in Alzheimer's disease and vascular dementiaMehrul Hasnain, W Victor R Vieweg
Acta Psychiatrica Scandinavica|May 14, 2011
Do we truly appreciate how difficult it is for patients with schizophrenia to adapt a healthy lifestyle?Mehrul Hasnain, W Victor R Vieweg
CNS Drugs|August 30, 2014
QTc interval prolongation and torsade de pointes associated with second-generation antipsychotics and antidepressants: a comprehensive reviewMehrul Hasnain, W Victor R Vieweg
Journal of Psychopharmacology (Oxford, England)|March 23, 2011
Mortality in schizophreniaMehrul Hasnain, W Victor R Vieweg, Briana Mezuk
Postgraduate Medicine|August 24, 2012
Weight gain and glucose dysregulation with second-generation antipsychotics and antidepressants: a review for primary care physiciansMehrul Hasnain, W Victor R Vieweg, Bruce Hollett
CNS Drugs|February 17, 2010
Metformin for atypical antipsychotic-induced weight gain and glucose metabolism dysregulation: review of the literature and clinical suggestionsMehrul Hasnain, W Victor R Vieweg, Sonja K Fredrickson
The American Journal of Medicine|May 21, 2013
The replyW Victor R Vieweg, Mehrul Hasnain, Robert H Howland
The American Journal of Medicine|February 21, 2012
Coordinated medical and psychiatric care in schizophreniaW Victor R Vieweg, Mehrul Hasnain, Ananda K Pandurangi
Journal of Psychiatry & Neuroscience : JPN|June 25, 2013
Escitalopram and QTc prolongationMehrul Hasnain, Robert H Howland, W Victor R Vieweg
Journal of Psychopharmacology (Oxford, England)|December 21, 2010
Metformin for obesity and glucose dysregulation in patients with schizophrenia receiving antipsychotic drugsMehrul Hasnain, Sonja K Fredrickson, W Victor R Vieweg
Pageof 5